Incidence of cardiotoxicity over time in patients with HER2-positive metastatic breast cancer on long term treatment with trastuzumab and the potential risk factors.

N. Nathalie Bouwer, T. G. Steenbruggen, H. N. Rier, J. J. E. M. Kitzen, K. J. Beelen, A. J. Ten Tije, P. C. De Jong, J. C. Drooger, C. Holterhues, J. Van Rosmalen, M. J. M. Kofflard, E. Boersma, G. S. Sonke, M-D Levin, A. Jager

Research output: Contribution to journalMeeting AbstractAcademicpeer-review

Original languageEnglish
Pages (from-to)289-290
Number of pages2
JournalEuropean Journal of Heart Failure
Volume21
Publication statusPublished - May 2019

Cite this